Stockreport

Cartesian Therapeutics Announces New Employment Inducement Grants

Cartesian Therapeutics, Inc.  (RNAC) 
PDF FREDERICK, Md., April 02, 2026 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a late clinical-stage biotechnology company pioneering [Read more]